News

Find News

Filter articles

Applied Filters

Showing 51 to 60 of 846 results

Gilead challenges US govt patents on HIV drug Truvada

US22-08-2019

Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug. 

Novo Nordisk seeks to block Mylan generic

US22-08-2019Rory O'Neill

Danish pharmaceutical company Novo Nordisk has sued Mylan in a US court over a proposed generic of diabetes drug Victoza (liraglutide).

Amneal and others pay $1.5m to settle antitrust suit over Alzheimer’s drug

US20-08-2019Sarah Morgan

Amneal and three other generic makers have agreed to pay $1.54 million to settle a class-action lawsuit, which alleged the companies engaged in an unlawful scheme to maintain their monopoly over an Alzheimer’s drug.

Fed Circuit majority ‘problematically’ adds new rule in Actavis suit: chief judge

US16-08-2019

The US Court of Appeals for the Federal Circuit yesterday, August 15, blocked Actavis’s attempt to market a generic version of Nalpropion Pharmaceuticals’ weight-loss drug Contrave.

Sanofi victorious at Fed Circ in prostate cancer drug dispute

15-08-2019Sarah Morgan

Sanofi secured a win at the US Court of Appeals for the Federal Circuit yesterday, August 14, after the appeals court concluded a lower court lacked authority to invalidate claims of a patent covering a prostate cancer drug.

Sandoz to appeal against Amgen biosimilar ruling

US13-08-2019Sarah Morgan

Sandoz has confirmed that it plans to appeal against a decision that upheld the validity of two of Amgen’s patents for its arthritis treatment Enbrel, effectively blocking the launch of Sandoz’s biosimilar version.

Fed Circ affirms Eli Lilly victories over cancer drugs

US13-08-2019Sarah Morgan

The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.

Akebia Therapeutics and Par Pharma settle Auryxia suit

US07-08-2019Saman Javed

A subsidiary of Akebia Therapeutics has entered into a settlement agreement with Endo-owned Par Pharmaceutical.

Allergan to pay $2.7m to settle antitrust suit over Asacol

US06-08-2019Saman Javed

A subsidiary of Irish pharmaceutical company Allergan is to pay a combined total of $2.7 million to three organisations that were part of an antitrust class against the drugmaker.

Bausch Health resolves IP litigation with Teva

US02-08-2019Sarah Morgan

Canadian pharmaceutical company Bausch Health and generics maker Teva have resolved their dispute over Apriso (mesalazine), a drug used to treat ulcerative colitis and Crohn's disease. 

Showing 51 to 60 of 846 results

LSIPR